CIPHER Study: Pilot Study to Study the Role of ctDNA in Triple Negative and HER2 Positive Early Stage
CIPHER Study: Pilot Study to Study the Role of ctDNA in Triple Negative and HER2 Positive Early Stage
Active, not recruiting · NCT05333874 · Registry updated 2026-02-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| CIPHER Study: Pilot Study to Study the Role of ctDNA in Triple Negative and HER2 Positive Early Stage | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder, triple-negative breast carcinoma | Active, not recruiting | Early phase 1 | 2026-02-09 | NCT05333874 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Rutgers, The State University of New Jersey | 154 |
12 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cooperman Barnabas Medical Center | Livingston | United States | 2 |
| Jersey City Medical Center | Jersey City | United States | 41 |
| Monmouth Medical Center | Long Branch | United States | 72 |
| Monmouth Medical Center - Southern Campus | Lakewood | United States | 1 |
| Monmouth Medical Center Vantage Point Infusion Cente | West Long Branch | United States | 1 |
| Newark Beth Israel Medical Center | Newark | United States | 97 |
| Robert Wood Johnson Barnabas Hospital -Somerset | Somerville | United States | 1 |
| Robert Wood Johnson University Hospital | New Brunswick | United States | 22 |
| Rutgers Cancer Institute of New Jersey | New Brunswick | United States | 223 |
| RWJBarnabas Health - Robert Wood Johnson University Hospital | Hamilton | United States | 4 |
| Steeplechase Cancer Center | Somerville | United States | 2 |
| Trinitas Hospital and Comprehensive Cancer Center | Elizabeth | United States | 5 |